ArticleJournal of Alzheimer's disease reports
Nipah virus infection as a putative risk factor for Alzheimer's disease: A testable hypothesis.
Article in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nipah virus is a neurotropic paramyxovirus known to cause severe acute encephalitis and delayed or relapsing neurological syndromes. Increasing evidence suggests that both systemic infections and central nervous system inflammation may act as contributors to, or accelerators of, Alzheimer's disease pathology. In this context, we propose that Nipah virus infection may confer long-term susceptibility to Alzheimer's disease through several converging mechanisms, including direct neuronal injury, sustained microglial activation mediated by Ephrin-B2/B3 receptor engagement, and persistent disruption of the blood-brain barrier. Clarifying this potential association would have important implications for long-term post-viral care and the broader infectious-disease framework for neurodegeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.